Skip to main content
Premium Trial:

Request an Annual Quote

EU Authorities Clear Invitrogen, ABI Merger

NEW YORK (GenomeWeb News) – Invitrogen and Applied Biosystems today said that European Union regulatory authorities have cleared their proposed $6.7 billion merger.
 
The deal already cleared US antitrust hurdles and is expected to close on Nov. 21, the firms said.
 
ABI stockholders have until the end of the business day on Nov. 19 to elect whether they will receive all cash, all stock, or a mix of the two in consideration for their shares.
 
As reported by GenomeWeb Daily News last week, the merged company will be called Life Technologies, rather than operating under the Applied Biosystems name, as initially planned.
 

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.